Abbott Laboratories Price
88.18₺ %-1.64-1.47
Last update:
High90.29 ₺
Low87.07 ₺
Volume13.66M
Market Cap153.59B
52W Low: 81.97-34.20%52W High: 139.06
After-Hours88.280.11%
- Open
- 89.62
- P/E
- 24.70
- Forward P/E
- 14.55
- P/B
- 2.95
- EPS (TTM)
- 3.57
- Forward EPS
- 6.0593
- Book Value
- 29.889
- Dividend Yield
- 2.72% (2.44)
- Dividend Date
- May 15, 2026
- 50-Day Avg
- 91.2152
- 200-Day Avg
- 114.4904
- Avg Volume (3M)
- 13.06M
- Shares Outstanding
- 1.74B
- Bid / Ask
- 87.78 / 88.36
- Analyst Rating
- 1.7 - Buy
- Next Earnings
- Apr 16, 2026
- Exchange
- NYSE
- Market State
- Closed
Company Data
Healthcare · Medical Devices · 122000 employees
| Forward P/E | 14.55 |
|---|---|
| PEG Ratio | 1.31 |
| Price/Book | 2.95 |
| Beta | 0.62 |
| Earnings Per Share (EPS) | 3.57 |
| 52-Week Change | %-34.2 |
| Enterprise Value (EV) | 181.1B |
| Shares Outstanding | 1.7B |
| Last Dividend | 0.63 (April 15, 2026) |
| Insider Ownership | %0.5 |
| Institutional Ownership | %82.66 |
| Net Profit Margin | %13.9 |
|---|---|
| Operating Margin | %13.47 |
| Return on Equity (ROE) | %12.33 |
| Return on Assets (ROA) | %5.59 |
| Revenue Growth | %7.8 |
| Earnings Growth | %-19.7 |
| Debt/Equity | 64.77 |
| Current Ratio | 1.39 |
Analyst Outlook
- Average Price Target
- 116.54
- Target Range
- 92 – 135
- Number of Analysts
- 24
- Consensus
- Buy
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 4 | 16 | 7 | 0 | 0 |
Company data is sourced from Yahoo Finance and may be delayed; this is not investment advice.
Abbott Laboratories News
- Is Abbott (ABT) the Best Longevity Stock to Buy Now?
- Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors
- Abbott declares 410th consecutive quarterly dividend
- BofA Adjusts Price Target on Abbott Laboratories to $102 From $120
- AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
- This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
News is sourced from Yahoo Finance; headlines link to external sources.
What Is Abbott Laboratories?
Abbott Laboratories (ABT) is a company share traded on Borsa İstanbul. This page shows the last trade price, daily change, and intraday movement for Abbott Laboratories. Data is updated during Borsa İstanbul session hours.
The Abbott Laboratories price is determined by supply and demand. The company's financial performance, sector dynamics, and the macro environment are the main determinants.
Factors Affecting the Abbott Laboratories Price
- Company quarterly financial results (EBITDA, net profit)
- Sector dynamics and the competitive environment
- Dividend policy and capital increase decisions
- Inclusion in/exclusion from BIST indices (liquidity effect)
- Macro conditions and the foreign ownership ratio
Frequently Asked Questions
- What is Abbott Laboratories?
- Abbott Laboratories (ABT) is a publicly traded company on Borsa İstanbul. Its shares are bought and sold under the symbol "ABT".
- What are the Abbott Laboratories trading hours?
- On Borsa İstanbul, pre-opening is 09:40-09:55 and continuous trading is 10:00-18:00 (lunch break 13:00-14:00).
- How is the Abbott Laboratories price determined?
- It is the last trade price at which buyer and seller are matched in the continuous auction system. The best bid and ask levels in the order book indicate liquidity.
- When does dividend distribution for Abbott Laboratories occur?
- Abbott Laboratories dividend distribution is determined by a general assembly decision; for past-year dividends you can follow the PDP (KAP) announcements.